Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

40.72
+0.25340.63%
Volume:9K
Turnover:379.04K
Market Cap:1.05B
PE:- -
High:40.89
Open:40.73
Low:40.57
Close:40.47
52wk High:42.87
52wk Low:27.30
Shares:25.75M
Float Shares:25.75M
Volume Ratio:0.34
T/O Rate:0.04%
Dividend:0.42
Dividend Rate:1.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

U.S. Research Roundup- Eli Lilly, McDonald's, Welltower

Reuters
·
1 hour ago

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
3 hours ago

JNJ Reports Low Rates of Treatment-Related Events for Rybrevant Faspro Plus Lazcluze at Wclc 2026

Reuters
·
5 hours ago

J&J - Fewer than 1% Discontinue Rybrevant Faspro Plus Lazcluze Due to Treatment-Related Events at One Year

THOMSON REUTERS
·
5 hours ago

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
6 hours ago

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
6 hours ago

Contineum Therapeutics Says Phase 2 Major Depressive Disorder Study Fails to Meet Primary Efficacy Endpoint

MT Newswires Live
·
11 hours ago

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
11 hours ago

Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint

Dow Jones
·
11 hours ago

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
11 hours ago

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
11 hours ago

Contineum, J&J's Depression Drug Fails to Meet Mid-Stage Trial Goal

Reuters
·
12 hours ago

Contineum Therapeutics, - Johnson & Johnson Continues to Evaluate Trial Data for Jnj-5120/Pipe-307

THOMSON REUTERS
·
12 hours ago

Merck & Co Exec Says Potential 340B and Policy Evolutions Would Create Tailwinds but are not Material to the Business - Morgan Stanley Conf

THOMSON REUTERS
·
12 hours ago

Merck & Co Exec Says Timing for Raising the $70 Bln Forecast is "to be Determined" Adds "It's Coming"

THOMSON REUTERS
·
12 hours ago

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
13 hours ago

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
13 hours ago

Eli Lilly Exec Says Co NOW Has More than 30% Share in New Starts Within Oral Obesity Treatment Market -Morgan Stanley Conf

THOMSON REUTERS
·
14 hours ago

Eli Lilly and Co Stock (LLY) Moved Up by 3.01% on Sep 14: Drivers Behind the Movement

TradingKey
·
16 hours ago

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Yesterday